New in @CommsBio from @ken1kamei & @KyotoU_News colleagues: "Integrated-gut-liver-on-a-chip platform as an in vitro human model of non-alcoholic fatty liver disease" https://t.co/8UL4a4pag8 #NAFLD #OOC #humanrelevantresearch
Integrated-gut-liver-on-a-chip platform as an in vitro human model of non-alcoholic fatty liver disease.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Jun 2020 – Jul 2023Where it's discussed
-
X / Twitter14 posts
-
YouTube1 videos
AI synopsis
What people are saying
The overall social discussions are highly supportive and curious, highlighting phrases like 'new in research' and tags such as #NAFLD and #organsonachip, which indicate strong interest in advancements and implications. The tone reflects excitement about the platform's potential to advance disease modeling and replace animal testing, demonstrating both academic engagement and perceived high impact.
Most discussions express positive acknowledgment and support for the significance of the research, indicating agreement with its value and potential.
The discussions show high interest, with multiple posts mentioning the innovative platform, potential impact, and collaborations, demonstrating curiosity and engagement.
Posts include references to the methodology, collaborations, and implications, reflecting moderate to high engagement levels, especially among researchers and academics.
The discussions suggest that the research could significantly influence future NAFLD studies and organ-on-a-chip technology, emphasizing its innovative approach and potential to replace animal testing.
Abstract in brief
- Non-alcoholic fatty liver disease (NAFLD) affects many people, but effective treatments are lacking due to limitations in current research methods.
- The study introduces an integrated-gut-liver-on-a-chip (iGLC) system that simulates human gut-liver interactions by co-culturing gut and liver cell lines in a microfluidic environment, allowing for observation of NAFLD development.
- Results show that gut-liver co-cultured cells can protect against fat-induced cell death, while providing insights into lipid accumulation and gene expression changes linked to cellular stress, suggesting the iGLC platform could replace animal testing for studying NAFLD.
Top posts
Most liked on X and BlueskyWe put our recent achievement in collaboration with Jiandong, Hirai sensei, and Iida sensei about Organs-on-a-Chip in bioRxiv! "Integrated gut-liver-on-a-chip platform as an in vitro human model of non-alcoholic fatty liver disease" #organsonachip #nafld https://t.co/wKnYRmHow1
Integrated-gut-liver-on-a-chip platform as an in vitro human model of non-alcoholic fatty liver disease - Communications Biology https://t.co/xooYfW8QdK (@CommsBio)
@ken1kamei @Eng_Kyoto_Univ Paper “Integrated gut–liver-on-a-chip platform as an in vitro human model of non-alcoholic fatty liver disease” https://t.co/KYgWpYGkAX @CommsBio
Paper Published. https://t.co/4f54EHREty
Integrated gut-liver-on-a-chip platform as an in vitro human model of non-alcoholic fatty liver disease https://t.co/3gwyal7baV #bioRxiv
All mentions
In Vitro Human Model of Non-Alcoholic Fatty Liver Disease Using Gut-Liver-on-a-Chip
This video explores an integrated gut-liver-on-a-chip platform that simulates human interactions between gut and liver cells, providing insights into non-alcoholic fatty liver disease development and potential for…
Integrated-gut-liver-on-a-chip platform as an in vitro human model of non-alcoholic fatty liver disease https://t.co/RuIdAE1a7o
Integrated-gut-liver-on-a-chip platform as an in vitro human model of non-alcoholic fatty liver disease | Communications Biology https://t.co/BRUI8Bw7rl
RT @iCeMS_KU: @ken1kamei @Eng_Kyoto_Univ 論文:“Integrated gut–liver-on-a-chip platform as an in vitro human model of non-alcoholic fatty live…
RT @iCeMS_KU_INTL: @ken1kamei @Eng_Kyoto_Univ Paper “Integrated gut–liver-on-a-chip platform as an in vitro human model of non-alcoholic fa…
@ken1kamei @Eng_Kyoto_Univ Paper “Integrated gut–liver-on-a-chip platform as an in vitro human model of non-alcoholic fatty liver disease” https://t.co/KYgWpYGkAX @CommsBio
@ken1kamei @Eng_Kyoto_Univ 論文:“Integrated gut–liver-on-a-chip platform as an in vitro human model of non-alcoholic fatty liver disease” https://t.co/fRutFphd2W @CommsBio
Integrated-gut-liver-on-a-chip platform as an in vitro human model of non-alcoholic fatty liver disease - Communications Biology https://t.co/xooYfW8QdK (@CommsBio)
New in @CommsBio from @ken1kamei & @KyotoU_News colleagues: "Integrated-gut-liver-on-a-chip platform as an in vitro human model of non-alcoholic fatty liver disease" https://t.co/8UL4a4pag8 #NAFLD #OOC #humanrelevantresearch
Paper Published. https://t.co/4f54EHREty
Integrated-gut-liver-on-a-chip platform as an in vitro human model of non-alcoholic fatty liver disease https://t.co/tK5hfKGdrR
RT @ken1kamei: We put our recent achievement in collaboration with Jiandong, Hirai sensei, and Iida sensei about Organs-on-a-Chip in bioRxi…
Integrated gut-liver-on-a-chip platform as an in vitro human model of non-alcoholic fatty liver disease https://t.co/queTzFU1C5
We put our recent achievement in collaboration with Jiandong, Hirai sensei, and Iida sensei about Organs-on-a-Chip in bioRxiv! "Integrated gut-liver-on-a-chip platform as an in vitro human model of non-alcoholic fatty liver disease" #organsonachip #nafld https://t.co/wKnYRmHow1
Integrated gut-liver-on-a-chip platform as an in vitro human model of non-alcoholic fatty liver disease https://t.co/3gwyal7baV #bioRxiv